chr20-62828755-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001853.4(COL9A3):c.901-9T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00604 in 1,612,596 control chromosomes in the GnomAD database, including 517 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.0085   (  72   hom.,  cov: 35) 
 Exomes 𝑓:  0.0058   (  445   hom.  ) 
Consequence
 COL9A3
NM_001853.4 intron
NM_001853.4 intron
Scores
 2
 Splicing: ADA:  0.0002385  
 2
Clinical Significance
Conservation
 PhyloP100:  -1.72  
Publications
2 publications found 
Genes affected
 COL9A3  (HGNC:2219):  (collagen type IX alpha 3 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010] 
COL9A3 Gene-Disease associations (from GenCC):
- epiphyseal dysplasia, multiple, 3Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
- Stickler syndromeInheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen
- Stickler syndrome, type 6Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- multiple epiphyseal dysplasia due to collagen 9 anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive Stickler syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74). 
BP6
Variant 20-62828755-T-C is Benign according to our data. Variant chr20-62828755-T-C is described in ClinVar as Benign. ClinVar VariationId is 194832.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.143  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00854  AC: 1299AN: 152174Hom.:  72  Cov.: 35 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1299
AN: 
152174
Hom.: 
Cov.: 
35
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0197  AC: 4903AN: 249348 AF XY:  0.0165   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
4903
AN: 
249348
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00578  AC: 8444AN: 1460304Hom.:  445  Cov.: 34 AF XY:  0.00546  AC XY: 3968AN XY: 726458 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
8444
AN: 
1460304
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
3968
AN XY: 
726458
show subpopulations 
African (AFR) 
 AF: 
AC: 
25
AN: 
33478
American (AMR) 
 AF: 
AC: 
2276
AN: 
44688
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26124
East Asian (EAS) 
 AF: 
AC: 
5256
AN: 
39692
South Asian (SAS) 
 AF: 
AC: 
246
AN: 
86246
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
52154
Middle Eastern (MID) 
 AF: 
AC: 
6
AN: 
5762
European-Non Finnish (NFE) 
 AF: 
AC: 
90
AN: 
1111798
Other (OTH) 
 AF: 
AC: 
544
AN: 
60362
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.484 
Heterozygous variant carriers
 0 
 518 
 1037 
 1555 
 2074 
 2592 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 138 
 276 
 414 
 552 
 690 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00851  AC: 1296AN: 152292Hom.:  72  Cov.: 35 AF XY:  0.00928  AC XY: 691AN XY: 74460 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1296
AN: 
152292
Hom.: 
Cov.: 
35
 AF XY: 
AC XY: 
691
AN XY: 
74460
show subpopulations 
African (AFR) 
 AF: 
AC: 
62
AN: 
41566
American (AMR) 
 AF: 
AC: 
391
AN: 
15308
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
787
AN: 
5176
South Asian (SAS) 
 AF: 
AC: 
25
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10610
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
14
AN: 
68018
Other (OTH) 
 AF: 
AC: 
17
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.497 
Heterozygous variant carriers
 0 
 64 
 129 
 193 
 258 
 322 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 22 
 44 
 66 
 88 
 110 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
203
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:7 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:4 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 20, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:2 
Oct 20, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Connective tissue disorder    Benign:1 
May 26, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 dbscSNV1_ADA 
 Benign 
 dbscSNV1_RF 
 Benign 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.